Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Sedation in Elderly Patients Undergoing Prostate Biopsy
NCT07854197Not yet recruiting
- Sponsor
- Renji Hospital
- Start
- Oct 2026
- Primary completion
- Jun 2027
01
Overview
Randomised trial of remimazolam (2 arms), sponsored by Renji Hospital. Primary endpoint: Incidence of composite adverse events during sedation. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT07854197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07854197.